Myocardial Perfusion SPECT Should NOT Be Routine in Symptomatic Patients with Excellent Exercise Capacity V. Froelicher, MD Professor of Medicine Stanford.

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

Clinical Exercise Physiology
Patient Oriented Therapy Non STE ACS
Cardiac Issues in Athletic Participation: To Screen or Not to Screen?
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
How to Use Heart Rate Changes to Improve Exercise Test Results V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS.
Better Medical Diagnostic Decisions thru Science V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS Optimal Clinical Application.
2/9/2014 The Prevalence and Prognostic Significance of ECG Abnormalities For: ECG in Ischemic Heart Disease By: V. Froelicher, MD Palo Alto VAHCS and Stanford.
Overview and Basics of Exercise Physiology
PET AND PET/CT IN ISCHEMIC HEART DISEASE
Approach to The Low Risk Chest Pain Patient John P Erwin, III, MD, FACC, FAHA Associate Professor of Medicine Scott and White Heart and Vascular Institute.
Case Study. Patient AH 51-year-old male patient family history of hyperlipidemia status post myocardial infarction x 2 (1995,1997) Coronary artery bypass.
Karam Paul MS, MD, MBA, FACC Community Heart and Vascular.
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI )
Management of LCA-LM dissection.
Pexelizumab for the Reduction of Infarction and Mortality in Coronary Artery Bypass Graft ll (PRIMO-CABG II) Trial Presented at The American College of.
CV Health: Three Ways to ‘kNOw’
Improving Office Care for Chest Pain Thomas D. Sequist, MD MPH Associate Professor of Medicine and Health Care Policy Brigham and Women ’ s Hospital, Division.
Listening to the Data: Why There’s Room for Improvement in MI Care Heartscape® Consultants Meeting Charles V. Pollack, Jr, MA, MD, FACEP, FAAEM, FAHA Chairman,
Lipid Management in 2015: Risk & Controversies
CARDIOVASCULAR DISEASE & WOMEN: A Review of The Evidence.
Exercise Stress Electrocardiography
B. C. Kansupada, MD, HeartCare Assoc. ACC chapter talk 4/28/06.
Cardiac Stress Testing. What is a stress test? A progressive graded test that reproduces diagnostic, prognostic, and functional abnormalities in clients.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A Classification Approach for Effective Noninvasive Diagnosis of Coronary Artery Disease Advisor: 黃三益 教授 Student: 李建祥 D 楊宗憲 D 張珀銀 D
Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Fleisher, L. A. et al. J Am Coll Cardiol 2007;50:e159-e242 Cardiac evaluation.
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
The Exercise Test V. Froelicher, MD Professor of Medicine
Modalities of Cardiac Stress Test
Screening for CAD: What Test to Order for Which Situation
Stress Testing Rajiv Perinbasekar. Stress Testing Electrocardiographic (ECG) stress testing Standard Echocardiographic (echo) stress testing Pharmacologic.
Stress testing Physiology: Sympathetic system activation increases: Heart rate Stroke volume Cardiac output Ventricular contractility Afterload (Vasoconstriction)
Exercise Treadmill Testing
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
Majelle L. Gagtan. Definition Indications/Contraindications Running the Exercise Test Protocols.
CLINICAL EXERCISE TESTING To evaluate person’s ability to tolerate increasing levels of work output parameters measured include but are not limited to.
Myocardial Ischemia: Concepts in Management Topics in Clinical Medicine February 14, 2007.
Silent Ischemia STABLE CAD
Risk Stratification In Patients With Chronic Myocardial Ischemia.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Sensitivity is True positives 60 Total CAD 100 Sensitivity and Specificity CAD by CAG No CAD by CAG TMT + VE True Positives 60 False Positives 60 TMT –
©2015 MFMER | slide-1 Stress Testing in Women Todd D. Miller, M.D. Mayo Clinic Rochester, MN Disclosures:
Prospective Randomized Comparison of Conventional Stress Echocardiography with Real Time Perfusion Stress Echocardiography in Predicting Clinical Outcome.
Adult Echocardiography Lecture 10 Coronary Anatomy
Insights from the PROMISE Trial Neha J. Pagidipati, MD MPH; Kshipra Hemal; Adrian Coles, PhD; Daniel B. Mark, MD MPH; Rowena J. Dolor, MD MHS; Patricia.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Cardiovascular Risk Factors Non-modifiable – Age – Gender – Family History Modifiable – Hypertension – Smoking – Diabetes – Hyperlipedemia – Other: Homocystine.
Prognostic value of MPI S.R.Zakavi,MD.IBNM Nuclear Medicine Research Center, Mashhad University of Medical Sciences Mashhad, Iran
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Screening for CAD Nuclear Medicine prospective S.R.Zakavi,MD,IBNM Nuclear Medicine Research Center Mashhad University of Medical Sciences.
Indication Contraindication Preparation
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Women and Cardiovascular Disease
Zoll Firm Lecture Series
Cardiac Indices in Myocardial Perfusion Scan and Their Impact on the Patient's Prognosis
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Adenosine-stress myocardial perfusion imaging in octogenarians:
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Prediction of 14-year cardiovascular outcomes by dobutamine.
Fractional Flow Reserve Workshop
European Heart Association Journal 2007 April
Giuseppe Biondi Zoccai, MD
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Characteristics and Outcomes of Patients Who Achieve High Workload (≥10 Metabolic Equivalents) During Treadmill Exercise Echocardiography  Nowell M. Fine,
Presentation transcript:

Myocardial Perfusion SPECT Should NOT Be Routine in Symptomatic Patients with Excellent Exercise Capacity V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS

Myocardial Perfusion SPECT Should NOT Be Routine in Symptomatic Patients with Excellent Exercise Capacity For simplicity sake let us avoid the philosophical issues regarding this: no test should be routine for all patients clinical judgment and the art of medicine (incldg patients own desires and needs) should be foremost in the decision to test or not to test. Quality of life issues: are you able to do everything you want to do?

Myocardial Perfusion SPECT Should NOT Be Routine in Symptomatic Patients with Excellent Exercise Capacity Assumptions: Symptoms equal chest pain Exercise capacity obtained from an exercise test. Excellent exercise capacity => 10 METs

What are the Questions being asked? Are these symptoms due to Coronary Disease? Do these symptoms put this patient at high risk for a Cardiac Event? Is a invasive intervention appropriate? If due to CAD, what is the culprit lesion? Does the baseline ECG invalidate ST analysis?

Regarding 2 of the Questions: If due to CAD, what is the culprit lesion? –ST depression does not localize, ST elevation does but rare … Then yes, SPECT needed Does the baseline ECG invalidate ST analysis? –More than one mm ST depression, LBBB, WPW, IVCD, paced rhythm …. Then yes, SPECT is needed

The other Questions Are these symptoms due to Coronary Disease? –If no resting ECG abnormalities and scores used the exercise ECG sufficient … then No, SPECT not needed Do these symptoms put this patient at high risk for a Cardiac Event? – DTS and other prognostic scores sufficient … then No, SPECT not needed Is an invasive intervention appropriate?

Comparison of Tests for Diagnosis of CAD

Variable Circle responseSum Maximal Heart Rate Less than 100 bpm = to 129 bpm = to 159 bpm = to 189 bpm = to 220 bpm =6 Exercise ST Depression 1-2mm =15 > 2mm =25 Age >55 yrs =20 40 to 55 yrs = 12 Angina History Definite/Typical = 5 Probable/atypical =3 Non-cardiac pain =1 Hypercholesterolemia? Yes=5 Diabetes? Yes=5 Exercise test Occurred =3 induced Angina Reason for stopping =5 Total Score: Males Choose only one per group <40=low prob 40-60= intermediate probability >60=high probability

Duke Treadmill Score (uneven lines)

Kaplan-Meier Survival curves for the all-comers prognostic score. SCORE = (1=yes, 0=no) METs 65 + History of CHF + History of MI or Q wave a=0, b=1, c=2, d=more than 2 METs equally important to clinical variables

Most pertinent: Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. JACC 1997;30(3):641-8 Cleveland Clinic: Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise perfusion: 3,400 patients CONCLUSIONS: In this clinically low risk group, estimated functional capacity was a strong and overwhelmingly important independent predictor of all-cause mortality among patients undergoing exercise Tl-201 SPECT testing.

Next Most pertinent: McCully RB, Roger VL, Mahoney DW, Burger KN, Click RL, Seward JB, Pellikka PA. J Am Coll Cardiol 2002 Apr 17;39(8): Outcome after abnormal exercise echo for patients with good exercise capacity. Methods: 1,874 patients with CAD who had good exercise capacity but abnormal exercise ECHOs; cardiac events (cardiac death or nonfatal MI). CONCLUSIONS: ECHO descriptors of the extent and severity of exercise-related LV dysfunction were of independent and incremental prognostic value. Stratification of patients into low- and higher risk subgroups was possible.

Ventilatory (VO 2 ) n Cardiac Output x a-v O2 Difference n VE x (% Inspired Air Oxygen Content - Expired Air Oxygen Content) n External Work Performed

What is a MET? Metabolic Equivalent Term 1 MET = "Basal" aerobic oxygen consumption to stay alive = 3.5 ml O2 /Kg/min By convention just divide ml O2/Kg/min by 3.5

Key MET Values (part 1) 1 MET = "Basal" = 3.5 ml O2 /Kg/min 2 METs = 2 mph on level 4 METs = 4 mph on level < 5METs = Poor prognosis if < 65; limit immediate post MI; cost of basic activities of daily living

Key MET Values (part 2) 10 METs = As good a prognosis with medical therapy as CABS 13 METs = Excellent prognosis, regardless of other exercise responses 16 METs = Aerobic master athlete 20 METs = Aerobic athlete

Importance of METs 10 to 15% increase in survival per MET Can be increased by 25% by a training program

Medicare Reported Tests

Cause of change in Practice? $ Not reimbursement but obvious superiority or impression of superiority of other testing $ The Doctor does the test he gets paid (the most) for … the Doctors Dilemma, GB Shaw, 1926 $ Are we getting our monies worth???

Medicare Costs and Savings (response to drop in TM reimbursement from $350 to $150) Change cost Treadmill test875,000 ($307 mil) 533,000 (80 mil) -227 mil Nuclear Perfusion (5-7x cost) 889,000 ($632 mil) 1.4 mil ($984 mil) +352 mil +126 mil